Population-based screening for cancer: hope and hype

Area of Science:

• Oncology
• Cancer Research
• Preventive Medicine

Background:

• Cancer screening programs have yielded valuable insights, with notable successes in cervical and colorectal cancer detection.
• Breast, prostate, and lung cancer screening face challenges due to tumor heterogeneity and the risk of overdiagnosis/overtreatment.

Purpose of the Study:

• To review lessons learned from diverse cancer screening experiences.
• To discuss current innovations and outline a framework for advancing cancer screening science.

Main Methods:

• Analysis of existing cancer screening program outcomes.
• Review of strategies to address limitations in current screening practices.
• Discussion of emerging innovations in cancer detection and treatment tailoring.

Main Results:

• Cervical and colorectal cancer screening success is linked to cancer homogeneity and identifiable precursors.
• Screening for breast, prostate, and lung cancers faces challenges from phenotypic heterogeneity, leading to overdiagnosis concerns.
• Innovations focus on identifying high-benefit individuals, increasing diagnostic yield, and utilizing molecular tests.

Conclusions:

• Continuous improvement in cancer screening requires cross-disciplinary learning and adaptation.
• Future screening advancements necessitate a dynamic framework to integrate new technologies and personalized approaches.
• Addressing tumor heterogeneity and overdiagnosis is crucial for optimizing cancer screening efficacy.